118 related articles for article (PubMed ID: 1317275)
1. A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs.
Villemaire C; Savard P; Talajic M; Nattel S
Circulation; 1992 Jun; 85(6):2255-66. PubMed ID: 1317275
[TBL] [Abstract][Full Text] [Related]
2. Modulation of procainamide's effect on cardiac conduction in dogs by extracellular potassium concentration. A quantitative analysis.
Villemaire C; Nattel S
Circulation; 1994 Jun; 89(6):2870-8. PubMed ID: 8205703
[TBL] [Abstract][Full Text] [Related]
3. Rate-dependent changes in intraventricular conduction produced by procainamide in anesthetized dogs. A quantitative analysis based on the relation between phase 0 inward current and conduction velocity.
Nattel S; Jing W
Circ Res; 1989 Dec; 65(6):1485-98. PubMed ID: 2582585
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of procainamide-induced rate-dependent conduction slowing by elevated myocardial extracellular potassium concentration in vivo.
Cascio WE; Foster JR; Buchanan JW; Johnson TA; Gettes LS
Circulation; 1987 Dec; 76(6):1380-7. PubMed ID: 3677360
[TBL] [Abstract][Full Text] [Related]
5. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
6. The effects of procainamide on conduction in anisotropic canine ventricular myocardium.
Kadish AH; Spear JF; Levine JH; Moore EN
Circulation; 1986 Sep; 74(3):616-25. PubMed ID: 3742759
[TBL] [Abstract][Full Text] [Related]
7. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
Kirchhof PF; Fabritz CL; Franz MR
Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.
Todt H; Zojer N; Raberger G
Br J Pharmacol; 1993 Sep; 110(1):145-50. PubMed ID: 8220875
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
[TBL] [Abstract][Full Text] [Related]
10. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
Nattel S
J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
[TBL] [Abstract][Full Text] [Related]
11. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
Liu W; Clarkson CW; Yamasaki S; Chang C; Stolfi A; Pickoff AS
J Pharmacol Exp Ther; 1992 Nov; 263(2):608-16. PubMed ID: 1331407
[TBL] [Abstract][Full Text] [Related]
13. Effect of procainamide on the postrepolarization refractoriness in cardiac muscle: evaluation using the block coupling interval in the artificial isthmus model in the canine right atrium.
Yoshizawa N; Niwano S; Moriguchi M; Kitano Y; Inuo K; Saito J; Izumi T
Pacing Clin Electrophysiol; 2001 Jul; 24(7):1100-7. PubMed ID: 11475826
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation.
Echt DS; Black JN; Barbey JT; Coxe DR; Cato E
Circulation; 1989 May; 79(5):1106-17. PubMed ID: 2469545
[TBL] [Abstract][Full Text] [Related]
15. Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Kidwell GA; Greenspon AJ; Greenberg RM; Volosin KJ
Circulation; 1993 Jan; 87(1):118-25. PubMed ID: 8418998
[TBL] [Abstract][Full Text] [Related]
16. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of verapamil and procainamide on rate-dependent bundle branch block: pharmacologic evidence for the role of depressed sodium channel responses.
Chiale PA; Pastori JD; Sánchez RA; Elizari MV; Rosenbaum MB
J Am Coll Cardiol; 1990 Mar; 15(3):633-9. PubMed ID: 2154512
[TBL] [Abstract][Full Text] [Related]
18. Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical.
Heath BM; Cui Y; Worton S; Lawton B; Ward G; Ballini E; Doe CP; Ellis C; Patel BA; McMahon NC
J Pharmacol Toxicol Methods; 2011; 63(3):258-68. PubMed ID: 21194571
[TBL] [Abstract][Full Text] [Related]
19. Epicardial mapping of polymorphous ventricular tachycardias induced in the canine heart with procainamide.
Murakawa Y; Inoue H; Toda I; Nozaki A; Kawakubo K; Sugimoto T
Am Heart J; 1988 May; 115(5):1037-42. PubMed ID: 3364336
[TBL] [Abstract][Full Text] [Related]
20. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
Valois M; Sasyniuk BI
Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
